Print

Print


   
   Has anyone documented the extent of sertraline 
   crossreactivity with benzodiazepine urine drug screening 
   methods, specifically the Abbott AxSYM method?
   
   Abbott's package insert says only that 1,000,000 ng/mL 
   sertraline (5-20 times the [parent + metabolites] 
   concentration expected on a recommended dose) will nudge 
   the result above the baseline (with no hint as to how far 
   above the baseline -- to the cutoff? beyond the cutoff?)
   
   Maybe the FDA could suggest how Abbott might improve the 
   usefulness of their package inserts.
   
   Robert Murray
   Lutheran General Hospital
   Park Ridge, Illinois
   USA


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%